Alternative splicing in cardiomyopathy

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Alternative splicing is an important mechanism used by the cell to generate greater transcriptomic and proteomic diversity from the genome. In the heart, alternative splicing is increasingly being recognised as an important layer of post-transcriptional gene regulation. Driven by rapidly evolving technologies in next-generation sequencing, alternative splicing has emerged as a crucial process governing complex biological processes during cardiac development and disease. The recent identification of several cardiac splice factors, such as RNA-binding motif protein 20 and 24, not only provided important insight into the mechanisms underlying alternative splicing but also revealed how these splicing factors impact functional properties of the heart. Here, we review our current knowledge of alternative splicing in the heart, with a particular focus on the factors controlling cardiac alternative splicing and their role in cardiomyopathies and subsequent heart failure.

Original languageEnglish
JournalBiophysical Reviews
Early online date26 Jul 2018
Publication statusPublished - 26 Jul 2018


Dive into the research topics of 'Alternative splicing in cardiomyopathy'. Together they form a unique fingerprint.

Cite this